Despite the challenges involved, small and emerging life sciences companies are conducting a significant percentage of the clinical trials in the U.S. These organizations are responsible for many of the industry’s pioneering innovations as they undertake considerable risk to drive clinical development forward. 

Often, these organizations work with lean teams, limited resources and minimal infrastructure. Yet they still need to collect, access and manage clinical trial data across all phases of their research, and administer the research itself.

This playbook describes why taking a low-code/no-code approach when building out your data collection and study management software platform is optimal for life sciences companies that want to balance customizability and control with ease of use and affordability. The playbook dives into: 

• The definition of and benefits of the low-code/no-code approach 
• How biopharmaceutical and MedTech innovators have availed themselves of these benefits to succeed in the real world 
• What to look for in a low-code/no-code eClinical platform

​